Literature DB >> 8847268

Mechanism of action of endothelin-1 in the canine pulmonary circulation.

S A Barman1, J R Pauly.   

Abstract

Possible mechanisms of action by which endothelin (ET)-1 has an effect on pulmonary vascular resistance and compliance in the canine pulmonary circulation were investigated in the isolated blood-perfused dog lung by use of vascular occlusion techniques. In the present study, ET-1 (10(-8) M) increased pulmonary vascular resistance and pulmonary capillary pressure by postcapillary vasoconstriction. In addition, ET-1 decreased total vascular compliance and middle-compartment compliance. Pretreatment with the ETA receptor antagonist BQ-610 (10(-7) M) or the protein kinase C inhibitors staurosporine (10(-6) M) and calphostin C (10(-6) M) completely blocked the pressor effect of ET-1. Elimination of extracellular calcium mobilization through voltage-dependent calcium channels by verapamil (10(-5) M) or modulation of G protein signal transduction by pertussis toxin challenge (15 micrograms/kg) had no significant effect on the ET-1-induced pulmonary vascular response. The results of the present study indicate that ET-1 causes pulmonary vasoconstriction in the canine pulmonary circulation through ETA receptor mediation and protein kinase C activation, possibly leading to intracellular calcium release. In contrast, the ET-1-induced pulmonary vascular response does not appear to involve extracellular calcium entry through voltage-dependent calcium-channel activation or pertussis toxin-sensitive G protein-signaling mechanisms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8847268     DOI: 10.1152/jappl.1995.79.6.2014

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  6 in total

1.  Role for PKCβ in enhanced endothelin-1-induced pulmonary vasoconstrictor reactivity following intermittent hypoxia.

Authors:  Jessica B Snow; Laura V Gonzalez Bosc; Nancy L Kanagy; Benjimen R Walker; Thomas C Resta
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-07-29       Impact factor: 5.464

Review 2.  Endothelin and its antagonists in hypertension: can we foresee the future?

Authors:  P Moreau; T J Rabelink
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

3.  Effect of nitric oxide on mitogen-activated protein kinases in neonatal pulmonary vascular smooth muscle.

Authors:  Scott A Barman
Journal:  Lung       Date:  2005 Sep-Oct       Impact factor: 2.584

4.  Protein kinase C modulation of cyclic GMP in rat neonatal pulmonary vascular smooth muscle.

Authors:  J A Johnson; S A Barman
Journal:  Lung       Date:  2004       Impact factor: 2.584

5.  Mechanism of endothelin-1 activation of MAP kinases in neonatal pulmonary vascular smooth muscle.

Authors:  Scott A Barman; Mario B Marrero
Journal:  Lung       Date:  2005 Nov-Dec       Impact factor: 2.584

Review 6.  Hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; Larissa A Shimoda; Philip I Aaronson; Jeremy P T Ward
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 46.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.